3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
2
Myocardial Reperfusion Injury
2
Cardiotoxicity
2
Vomiting
1
Uveal Melanoma
1
Thrombosis
1
Retinal Diseases
1
Reperfusion Injury
1
Pain, Postoperative
1
Nausea
1
Melanoma
1
Macular Degeneration
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Choroid Diseases
1
Breast Neoplasms
1
Interventions
Bupivacaine
32
Ropivacaine
19
Saline Solution
17
Dexmedetomidine
17
Morphine
12
Ketamine
11
Sodium Chloride
10
Acetaminophen
10
Lidocaine
9
Pregabalin
7
Control Groups
7
Dexamethasone
5
Gabapentin
4
Epinephrine
4
Anesthetics, Local
4
Analgesia, Patient-Controlled
4
parecoxib
3
oxycodone-acetaminophen
3
Tea
3
Surgical Procedures, Operative
3
Midazolam
3
Ketorolac
3
Injections, Epidural
3
Fentanyl
3
Esketamine
3
Dental Occlusion
3
Anti-Inflammatory Agents, Non-Steroidal
3
Anesthesia, General
3
Analgesics, Opioid
3
Vitamins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain, Postoperative
×
salicylhydroxamic acid
×
Clear all
NCT04085237
2026-06-04
ESPB
McMaster University
Phase NA
Terminated
10 enrolled